Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect
- 15 August 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 43 (4) , 491-495
- https://doi.org/10.1016/0049-3848(86)90094-0
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparationThrombosis Research, 1984
- Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfateThrombosis Research, 1984
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980